Total planned funding: $473,472,817
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $117,483,319 |
Zambia | $47,546,713 |
Mozambique | $44,002,338 |
South Africa | $37,298,813 |
Zimbabwe | $29,468,423 |
Asia Regional Program | $24,871,345 |
Tanzania | $24,087,800 |
Vietnam | $19,010,713 |
West Africa Region | $18,148,918 |
Botswana | $14,494,003 |
Burundi | $10,505,040 |
Democratic Republic of the Congo | $10,423,755 |
Kenya | $9,475,519 |
Côte d'Ivoire | $8,845,402 |
Haiti | $7,848,100 |
Ghana | $6,982,500 |
Dominican Republic | $5,798,850 |
Malawi | $5,578,259 |
India | $4,650,000 |
Rwanda | $4,308,060 |
Papua New Guinea | $3,494,885 |
Eswatini | $3,391,755 |
Uganda | $3,123,638 |
South Sudan | $2,868,967 |
Indonesia | $2,330,000 |
Angola | $2,250,000 |
Namibia | $1,947,275 |
Lesotho | $1,888,960 |
Ethiopia | $1,049,467 |
enumerations.Philippines | $300,000 |
Cambodia | $0 |
Caribbean Region | $0 |
Organizational Types
NGO | $473,472,817 |
Program Areas
Treatment | $130,495,177 |
Care | $128,286,817 |
Prevention | $118,005,704 |
Testing | $48,477,758 |
Governance and Systems | $48,045,067 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $118,517,175 |
HVOP: Sexual Prevention: Other Sexual Prevention | $70,516,539 |
HKID: Care: Orphans and Vulnerable Children | $63,486,267 |
HVCT: Testing: HIV Testing and Counseling | $48,477,758 |
HBHC: Care: Adult Care and Support | $45,956,741 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $25,755,000 |
OHSS: Health Systems Strengthening | $17,494,721 |
HLAB: Laboratory Infrastructure | $17,280,179 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,128,350 |
HVSI: Strategic Information | $13,270,167 |
PDTX: Treatment: Pediatric Treatment | $11,978,002 |
HVTB: Care: TB/HIV | $10,516,321 |
PDCS: Care: Pediatric Care and Support | $8,327,488 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,699,544 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,447,579 |
HMIN: Biomedical Prevention: Injection Safety | $343,860 |
HVMS: Management and Operations | $162,294 |
HMBL: Biomedical Prevention: Blood Safety | $114,832 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$473,472,817
View countries